| Literature DB >> 11805954 |
R C Elkins1, M M Lane, S B Capps, C McCue, P E Dawson.
Abstract
The humoral immune response to allograft heart valves as measured by PRA was absent in 52 of 57 (91%) patients at 1 month and was absent in 43 of 49 (88%) at 3 months in allograft valves treated with the SynerGraft process for antigen reduction. Short-term valve function is satisfactory. This may be associated with improved durability and long-term function. Copyright 2001 by W.B. Saunders CompanyEntities:
Mesh：
Substances：
Year: 2001 PMID： 11805954
Source DB: PubMed Journal: Semin Thorac Cardiovasc Surg ISSN： 1043-0679